2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
5
Observational
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
2936
Neoplasms
2634
Lung Neoplasms
1371
Colorectal Neoplasms
1332
Prostatic Neoplasms
1216
Carcinoma, Non-Small-Cell Lung
1080
Carcinoma, Hepatocellular
784
Stomach Neoplasms
721
Pancreatic Neoplasms
704
Ovarian Neoplasms
586
Colonic Neoplasms
534
Uterine Cervical Neoplasms
497
Head and Neck Neoplasms
496
Rectal Neoplasms
472
Melanoma
467
Multiple Myeloma
463
Esophageal Neoplasms
423
Neoplasm Metastasis
418
Brain Neoplasms
405
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Urinary Bladder Neoplasms
387
Leukemia, Myeloid, Acute
387
Leukemia
339
Carcinoma, Renal Cell
329
Liver Neoplasms
320
Endometrial Neoplasms
319
Hematologic Neoplasms
313
Recurrence
298
Disease
275
Interventions
Transurethral Resection of Prostate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder, Neurogenic
×
Clear all
NCT05182853
2022-01-11
TSC-URO
University Hospital, Montpellier
Completed
8 enrolled
NCT03698721
2018-10-09
IMOPU
Central Hospital, Nancy, France
Not yet recruiting
365 enrolled